Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2018 / Cilt: 23 - Sayı: 4

Epidemiology and Clinical Features of Seasonal Influenza Cases Followed in Our Clinic

Kliniğimizde Takip Ettiğimiz Mevsimsel İnfluenza Olgularının Epidemiyolojisi ve Klinik Özellikleri

Pages
223–226
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Given the reduced morbidityand mortality rates associated with vaccination and cost effectiveness, it is important to raise public awareness of vaccination, especiallyin the high-risk group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Seasonal influenza is a vaccine-preventable disease with high mortality and morbidity rate in the presence of old age, pregnancy andcomorbid diseases.
📊
Key Findings & Data:When we evaluated 151 patients with seasonal influenza in the 2015-2016 season, we found that the average ageof the patients, comorbid diseases such as chronic obstructive pulmonary disease (COPD) and cardiovascular diseases, and the needfor intensive care were high in these patients.
💡
Conclusion & Impact:Given the reduced morbidityand mortality rates associated with vaccination and cost effectiveness, it is important to raise public awareness of vaccination, especiallyin the high-risk group.
🔬Design:Research Article
📍Scope:2015-2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Seasonal influenza is a vaccine-preventable disease with high mortality and morbidity rate in the presence of old age, pregnancy andcomorbid diseases. When we evaluated 151 patients with seasonal influenza in the 2015-2016 season, we found that the average ageof the patients, comorbid diseases such as chronic obstructive pulmonary disease (COPD) and cardiovascular diseases, and the needfor intensive care were high in these patients. However, only two of these patients had vaccination history. Given the reduced morbidityand mortality rates associated with vaccination and cost effectiveness, it is important to raise public awareness of vaccination, especiallyin the high-risk group.

Özet

Mevsimsel grip, özellikle yaşlılık, gebelik ve komorbid hastalıkların bulunması durumunda mortalitesi ve morbiditesi yüksek olan aşı ile önlenebilen bir hastalıktır. 2015-2016 sezonunda mevsimsel grip tanısı ile takip ettiğimiz 151 hastayı değerlendirdiğimizde hastaların yaş ortalamasının yüksek, kronik obstrüktif akciğer hastalığı (KOAH) ve kardiyovasküler hastalık gibi komorbid hastalıkların fazla olduğunu ve bu hastalarda yoğun bakım ihtiyacının fazla olduğunu gördük. Ancak bu hastaların sadece 2 tanesinde aşılanma öyküsü vardı. Aşılamaya bağlı morbidite ve mortalitede azalma ve maliyet etkinliği göz önünde bulundurulduğunda özellikle yüksek risk grubunda aşılama konusunda toplumun bilinçlendirilmesi önemlidir.

🔖

Cite This Article

ÇELİK, İ., TÜRE, Z., DURSUN, Z. B., İNANICI, B. (2022). Epidemiology and Clinical Features of Seasonal Influenza Cases Followed in Our Clinic. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 23 - Sayı: 4, 223–226. https://ajindex.com/articles/517128

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Chiarella FC, Daoud Z, Fuentes-Ferrer ME, Ramos-Amador JT, Picazo JJ, Culebras E. Characterization and circulation of sseasonal influenza viruses in Madrid, 2010-2016. J Med Virol 2017;89:1726-33. http://www.who.int/mediacentre/factsheets/fs211/en. Availabledate, 2016.
  2. Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Bresee JS, Fry AM, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices-united states, 2017-18 influenza season. MMWR Recomm Rep 2017;66:1-20. (http://ekmud.org.tr/files/uploads/files/EriskinBagisiklamaRehberi-web-1.pdf (available date:02.11.2017).
  3. Filleul L, Ranoaritiana DB, Balleydier E, Vandroux D, Ferlay C, Jaffar-Bandjee M, et al. A majör impact of the influenza seasonal epidemic on intensive care units, Réunion, April to August 2016. Euro Surveill 2016;21:pii:30405. Thommes EW, Kruse M, Kohli M, Sharma R, Noorduyn SG. Review of seasonal influenza in Canada: burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines. Human Vaccınes&Immunotherapeutics 2017;13:867-76.
  4. Kuliese M, Jancoriene L, Grimalauskaite R, Zablockiene B, Damuleviciene G, Velyvyte D, et al. Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza in 2015-2016: a hospital-based test-negative case-control study in Lithuania. BMJ Open 2017;7:e017835. Choi WS, Cowling BJ, Noh JY, Song JY, Wie SH, Lee JS, et al. Disease burden of 2013-2014 seasonal influenza in adults in Korea. PLoS ONE 2017;12:e0172012.
  5. Zhang Y, Wu P, Feng L, Yang P, Pan Y, Feng S, et al. Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China. Vaccine 2017;35:3129-34.
  6. Kissling E, Valenciano M. Early influenza vaccine effectiveness results 2015-16: I-MOVE multicentre case-control study.Euro Surveill 2016;21.